| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/26/2012 | EP2501407A1 Anti-orai1 antigen binding proteins and uses thereof |
| 09/26/2012 | EP2501406A1 Biosynthetic system that produces immunogenic polysaccharides in prokaryotic cells |
| 09/26/2012 | EP2501405A1 Compositions, methods and uses for poxvirus elements in vaccine constructs |
| 09/26/2012 | EP2501404A1 Use of newcastle disease virus-based vector for inducing an immune response in mammals |
| 09/26/2012 | EP2501403A2 (poly)-glycerolphosphate-based anti-gram positive bacterial vaccine |
| 09/26/2012 | EP2501397A2 Methods for producing an immune response to tuberculosis |
| 09/26/2012 | EP2501396A1 LOW ANTIGEN-DOSE IMMUNIZATION FOR MAXIMIZING T-HELPER CELL 1 (T h1) IMMUNITY AGAINST DISEASE |
| 09/26/2012 | EP2501395A1 Par-1 antagonists for use in the treatment or prevention of influenza virus type a infections |
| 09/26/2012 | CN1980696B Method and system to remove soluble TNFR1, TNFR2, and IL2 in patients |
| 09/26/2012 | CN1980694B Use of gelsolin to treat infections |
| 09/26/2012 | CN1942483B Anti-P-selectin antibodies |
| 09/26/2012 | CN1909921B Compositions for reducing bacterial carriage and cns invasion and methods of using same |
| 09/26/2012 | CN1788088B Mutant vesicular stomatitis viruses and use thereof |
| 09/26/2012 | CN1738618B Pharmaceutical compositions and uses thereof |
| 09/26/2012 | CN1679929B Streptococcal c5a peptidase vaccine |
| 09/26/2012 | CN1674933B 疫苗组合物 Vaccine compositions |
| 09/26/2012 | CN1662663B DNA enzyme to inhibit plasminogen activator inhibitor-1 |
| 09/26/2012 | CN102695791A Protein glycosylation |
| 09/26/2012 | CN102695722A Antibodies and epitopes specific to misfolded prion protein |
| 09/26/2012 | CN102695524A Virus like particles comprising target proteins fused to plant viral coat proteins |
| 09/26/2012 | CN102695523A Combination vaccines against respiratory tract diseases |
| 09/26/2012 | CN102695522A New human rotavirus strains and vaccines |
| 09/26/2012 | CN102690879A Application of CDK17 gene and expression product thereof |
| 09/26/2012 | CN102690878A Application of CDK18 gene and expression product thereof |
| 09/26/2012 | CN102690877A Application of CSNK1A1 gene and expression product thereof |
| 09/26/2012 | CN102690876A Application of CSNK1G3 gene and expression product thereof |
| 09/26/2012 | CN102690875A Application of CDK14 gene and expression product thereof |
| 09/26/2012 | CN102690872A Application of TRIM28 gene and its expression product |
| 09/26/2012 | CN102690871A Application of TEX14 gene and its expression product |
| 09/26/2012 | CN102690868A Application of PDK3 gene and its expression product |
| 09/26/2012 | CN102690867A Application of NLK gene and its expression product |
| 09/26/2012 | CN102690866A Application of TRPM7 gene and its expression product |
| 09/26/2012 | CN102690865A MELK gene and application of its expression product |
| 09/26/2012 | CN102690791A Method for generating porcine pseudorabies virus by culturing ST cell in microcarrier of bioreactor |
| 09/26/2012 | CN102690789A Hybridoma cell strain secreting tetanus exotoxin monoclonal antibody, monoclonal antibody prepared by same, Fab antibody and application |
| 09/26/2012 | CN102690350A Anti-il-22ra antibodies and binding partners and methods of using in inflammation |
| 09/26/2012 | CN102690340A Recombined Brazil nut allergen and mutant and preparation method and applications thereof |
| 09/26/2012 | CN102690334A Purification method of virus vaccine |
| 09/26/2012 | CN102690327A Enterovirus 71 neutralized epitope polypeptide and application thereof |
| 09/26/2012 | CN102688502A Preparation process for gene vaccines containing UreB and CagA protein of helicobacter pylori |
| 09/26/2012 | CN102688488A Mucosal adjuvant and its preparation method and use |
| 09/26/2012 | CN102688487A Production method of newcastle disease (ND), infectious bronchitis (IB), infectious bursal disease virus (IBD) and viral arthritis (VA) four-joint inactivated vaccine |
| 09/26/2012 | CN102688486A Production method of triple inactivated vaccine for newcastle disease, infectious bursal disease and viral arthritis |
| 09/26/2012 | CN102688485A Preparation method of porcine parvovirus inactivated vaccine |
| 09/26/2012 | CN102688484A Production method for an inactivated vaccine for type-C Clostridial enteritis |
| 09/26/2012 | CN102329780B Anti-mycoplasma ST (swine testis) cell, and methods for culturing hog cholera virus low virulent strain and preparing hog cholera attenuated vaccine using same |
| 09/26/2012 | CN102258777B Method for preparing inactivated vaccine and combined vaccine by breeding infectious bursal disease virus (IBDV) by chicken embryo source cell line |
| 09/26/2012 | CN102180951B Cholesterol modified anti-human immunodeficiency virus (HIV) polypeptide medicament and application thereof |
| 09/26/2012 | CN102154184B Attenuated Salmonella pullorum and application thereof |
| 09/26/2012 | CN102091328B Staphylococcus hyicus inactivated vaccines, preparation method thereof and application thereof |
| 09/26/2012 | CN101972477B Zinc phosphate vaccine adjuvant |
| 09/26/2012 | CN101962400B Linear epitope minimum motif peptide of human papilloma virus type 58 L1 protein and application thereof |
| 09/26/2012 | CN101883571B Agent for promoting the secretion of adiponectin and/or inhibiting the decrease in the secretion of adiponectin |
| 09/26/2012 | CN101785857B Novel pneumococcal conjugate vaccine and preparation method thereof |
| 09/26/2012 | CN101622011B Methods of releasing sporocysts from oocysts using controlled shear forces |
| 09/26/2012 | CN101575607B Recombinant BCG vaccine based on human MUC1 repetitive sequence and GM-CSF fusion expression |
| 09/26/2012 | CN101522218B Vaccine comprising an oil in water emulsion adjuvant |
| 09/26/2012 | CN101494970B Oral formulation for enteric disorders and/or rehydration |
| 09/26/2012 | CN101253264B 抗血小板膜糖蛋白Ⅵ单克隆抗体 Anti-platelet membrane glycoprotein monoclonal antibody Ⅵ |
| 09/26/2012 | CN101186650B Antibody against secreted N-terminal peptide or C-terminal peptide of GPC3 present in blood |
| 09/26/2012 | CN101128485B Monoclonal antibodies against angiopoietin-like protein 4 (ANGPTL4) |
| 09/26/2012 | CN101128484B Compositions and methods relating to anti IGF-1 receptor antibodies |
| 09/26/2012 | CN101068568B Anti-malaria prime/boost vaccines |
| 09/25/2012 | US8273865 Multivalent clostridial toxins |
| 09/25/2012 | US8273859 Diagnostic agent and therapeutic agent for pancreatic cancer |
| 09/25/2012 | US8273858 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 09/25/2012 | US8273724 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 09/25/2012 | US8273705 Conversion of apoptotic proteins |
| 09/25/2012 | US8273568 Replication-competent herpes simplex virus mediates destruction of neoplastic cells |
| 09/25/2012 | US8273548 Nucleic acids encoding a human PAP1 polypeptide |
| 09/25/2012 | US8273541 Compositions and methods for detecting TLR3 |
| 09/25/2012 | US8273530 Method for simultaneous analysis of multiple biological reactions or changes in in vivo conditions |
| 09/25/2012 | US8273527 Viral variants |
| 09/25/2012 | US8273361 Vaccine composition containing synthetic adjuvant |
| 09/25/2012 | US8273360 Neisseria membrane protein mixture for use in developing vaccine to prevent bacterial infection; bactericides; immunotherapy |
| 09/25/2012 | US8273359 Therapeutic use of at least one botulinum neurotoxin in the treatment of pain induced by at least one anti-neoplastic agent |
| 09/25/2012 | US8273358 Activatable clostridial toxins |
| 09/25/2012 | US8273357 Antigen-carbohydrate conjugates |
| 09/25/2012 | US8273356 Anti-IgE vaccines |
| 09/25/2012 | US8273355 Hepatocyte growth factor (HGF) binding proteins |
| 09/25/2012 | US8273354 Anti-RSV G protein antibodies |
| 09/25/2012 | US8273353 Inhibitors of vascular endothelial growth factor activity |
| 09/25/2012 | US8273352 Humanized anti-factor D antibodies and uses thereof |
| 09/25/2012 | US8273351 Fc receptor binding proteins |
| 09/25/2012 | US8273350 Antibodies to human IL-1β |
| 09/25/2012 | US8273349 Binding member which binds to both lewis-Y and lewis-B haptens, and its use for treating cancer |
| 09/25/2012 | US8273328 Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof |
| 09/25/2012 | CA2664137C Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 09/25/2012 | CA2522994C Nucleic acids and corresponding proteins entitled 109p1d4 useful in treatment and detection of cancer |
| 09/25/2012 | CA2491524C Vaccine against salmonid rickettsial septicaemia |
| 09/25/2012 | CA2478049C Humanized antibodies that recognize beta amyloid peptide |
| 09/25/2012 | CA2428438C Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases |
| 09/25/2012 | CA2323681C Development of human monoclonal antibodies and uses thereof |
| 09/25/2012 | CA2189778C Use of fas ligand to suppress lymphocyte-mediated immune responses |
| 09/20/2012 | WO2012126013A2 Method for making pluripotent stem cells |
| 09/20/2012 | WO2012125998A1 Yeast-brachyury immunotherapeutic compositions |
| 09/20/2012 | WO2012125864A2 Overcoming resistance to erbb pathway inhibitors |
| 09/20/2012 | WO2012125775A1 Uses of a dual v region antibody-like protein |
| 09/20/2012 | WO2012125680A1 Methods of treating vasculitis using an il-17 binding molecule |
| 09/20/2012 | WO2012125658A1 Aerosolized thermostable granular particulate vaccine preparation |